Aarhus University Seal / Aarhus Universitets segl

Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

BACKGROUND: While some experimental and clinical research suggests that statins improve outcomes after severe infections, the evidence for pneumonia is conflicting. We examined whether preadmission statin use decreased risk of death, bacteremia, and pulmonary complications after pneumonia. METHODS: We conducted a population-based cohort study of 29,900 adults hospitalized with pneumonia for the first time between January 1, 1997, and December 31, 2004 in northern Denmark. Data on statin and other medication use, comorbidities, socioeconomic markers, laboratory findings, bacteremia, pulmonary complications, and death were obtained from medical databases. We used regression analyses to compute adjusted mortality rate ratios within 90 days and relative risks of bacteremia and pulmonary complications after hospitalization in both statin users and nonusers. RESULTS: Of patients with pneumonia, 1371 (4.6%) were current statin users. Mortality among statin users was lower than among nonusers: 10.3% vs 15.7% after 30 days and 16.8% vs 22.4% after 90 days, corresponding to adjusted 30- and 90-day mortality rate ratios of 0.69 (95% confidence interval, 0.58-0.82) and 0.75 (0.65-0.86). Decreased mortality associated with statin use remained robust in various subanalyses and in a supplementary analysis using propensity score matching. In contrast, former use of statins and current use of other prophylactic cardiovascular drugs were not associated with decreased mortality from pneumonia. In statin users, adjusted relative risk for bacteremia was 1.07 (95% confidence interval, 0.69-1.67) and for pulmonary complications was 0.69 (0.42-1.14). CONCLUSION: The use of statins is associated with decreased mortality after hospitalization with pneumonia.
Original languageEnglish
JournalArchives of Internal Medicine
Volume168
Issue19
Pages (from-to)2081-7
Number of pages6
ISSN0003-9926
DOIs
Publication statusPublished - 2008

    Research areas

  • Adolescent, Adult, Aged, Aged, 80 and over, Bacteremia, Cardiovascular Diseases, Cohort Studies, Denmark, Female, Hospitalization, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Logistic Models, Male, Middle Aged, Odds Ratio, Pneumonia

See relations at Aarhus University Citationformats

ID: 14799909